Quarterly report pursuant to Section 13 or 15(d)

Concentrations

v3.8.0.1
Concentrations
3 Months Ended
Mar. 31, 2018
Risks And Uncertainties [Abstract]  
Concentrations

NOTE 12—CONCENTRATIONS

Revenue from the Company’s products for the three months ended March 31, 2018 and 2017 are as follows:  

 

 

Three Months Ended

 

 

March 31,

 

 

2018

 

 

2017

 

Laser systems

$

5,703

 

 

57.0

%

 

$

6,729

 

 

61.9

%

Imaging systems

 

583

 

 

5.8

%

 

 

626

 

 

5.7

%

Consumables and other

 

2,034

 

 

20.3

%

 

 

1,692

 

 

15.6

%

Services

 

1,697

 

 

16.9

%

 

 

1,795

 

 

16.5

%

License fees and royalties

 

3

 

 

0.0

%

 

 

32

 

 

0.3

%

Total revenue

$

10,020

 

 

100.0

%

 

$

10,874

 

 

100.0

%

 

No individual customer represented more than 10% of the Company’s revenue for the three months ended March 31, 2018 or 2017.

The Company maintains its cash and cash equivalent accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

No individual customer represented more than 10% of the Company’s accounts receivable at March 31, 2018 or December 31, 2017.

The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s business, results of operations and financial condition.